0.024% of GDP: India Proposes to Sextuple Health Research Spending by 2047
UPSC-standard MCQs with explanations, trap analysis, and approach guide. Answer after the test — not before.
1
Easy
1
Medium
1
Hard
Practice this set
3 questions · full analysis after submission · no sign-up required
Article summary
The Department of Health Research has released the Draft National Health Research Policy, 2026 for public comment until 27 July, proposing the first unified national framework covering all areas of health research. Its headline commitment is fiscal: India currently spends about 0.024 per cent of GDP on health research, against an average of roughly 0.27 per cent in high-income countries, and the draft proposes raising this to 0.072 per cent by 2037 and 0.15 per cent by 2047 — a roughly six-fold increase in government research funding over two decades. It identifies priority areas including tuberculosis, antimicrobial resistance, vector-borne diseases, cancer, non-communicable diseases, mental health, anaemia, child malnutrition, women's health, maternal and neonatal mortality, primary healthcare and emergency care. Governance is proposed through a National Health Research Stewardship Committee for strategic coordination, with the Department of Health Research as nodal implementing agency and the Indian Council of Medical Research as scientific and technical lead. The more consequential shift is in evaluation: the draft would expand use of the ICMR Impact of Research and Innovation Scale, introduced in 2025, assessing researchers on whether their work changed clinical guidelines, public health programmes and policy — not on publication counts.
What this tests
Sample questions — answers revealed after test
Q1. With reference to the Draft National Health Research Policy, 2026, which one of the following statements is correct?
Q2. A commentator observes that even if the draft's 2047 target were fully achieved, India would not have caught up with high-income countries. Which one of the following best supports that observation?
Q3. Consider the following statements regarding the Draft National Health Research Policy, 2026: 1. The Department of Health Research is the nodal implementing agency, the Indian Council of Medical Research the scientific and technical lead, and a National Health Research Stewardship Committee provides strategic coordination. 2. The ICMR Impact of Research and Innovation Scale, introduced in 2025, assesses whether research contributed to clinical guidelines, public health programmes and policymaking, rather than counting publications. 3. Antimicrobial resistance has been excluded from the draft's priority areas on the ground that it is addressed under a separate national action plan. Which of the statements given above are correct?